Calpain 15, also referred to as SOLH (sol homologue), is a member of the calpain family of calcium-dependent cysteine proteases. Calpains play crucial roles in various cellular processes, such as cytoskeletal remodeling, cell motility, signal transduction, and protein degradation. Calpain 15 shares the structural and functional characteristics typical of calpains, including the presence of EF-hand motifs, a conserved cysteine protease domain, and regulatory domains that respond to calcium. Inhibitors targeting Calpain 15 have been the subject of interest in biochemical research due to the enzyme's involvement in intricate cellular processes. These inhibitors typically act by blocking the active site of the enzyme or by modulating the conformational states required for its calcium-dependent activation, thus preventing proteolysis of target substrates.
The design of Calpain 15 inhibitors often involves specific modifications to peptide-like scaffolds or small molecules to improve selectivity and binding affinity. Structural analysis of Calpain 15 reveals that subtle differences in the protease domain compared to other calpains can be exploited to create more selective inhibitors. This selectivity is important to avoid off-target effects on other calpains, given their widespread cellular functions. Inhibitors are typically designed to mimic the structure of the enzyme's natural substrates or transition states, effectively competing for the active site. Additionally, non-peptidic small molecules have been explored for their ability to interact with regulatory domains of the enzyme, potentially offering alternative mechanisms of inhibition. These compounds can disrupt calcium binding or interfere with domain interactions necessary for the protease's function, offering valuable insights into calpain biochemistry.
関連項目
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $119.00 $447.00 | 28 | |
酵素の活性部位に結合し、基質へのアクセスを阻害し、活性を阻害する選択的カルパイン阻害剤。 | ||||||
MDL-28170 | 88191-84-8 | sc-201301 sc-201301A sc-201301B sc-201301C | 10 mg 50 mg 100 mg 500 mg | $68.00 $236.00 $438.00 $2152.00 | 20 | |
強力で細胞透過性のカルパイン阻害剤であり、血液脳関門を通過し、活性部位に結合してプロテアーゼを阻害する。 | ||||||
PD 150606 | 179528-45-1 | sc-222133 sc-222133A | 5 mg 25 mg | $116.00 $395.00 | 18 | |
カルパインのカルシウム結合部位に選択的に結合し、活性化に必要な構造変化を阻止する阻害剤。 | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
カルパインの活性部位のシステイン残基に共有結合し、長期間の阻害をもたらす不可逆的阻害剤。 | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $72.00 $145.00 $265.00 $489.00 $1399.00 $99.00 | 19 | |
システインプロテアーゼの活性部位チオール基を標的とする可逆的阻害剤で、カルパインの活性を阻害する。 | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
酵素の活性部位と可逆的に相互作用してカルパインを阻害するペプチドアルデヒド。 | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
プロテアソームと不可逆的に結合することで間接的にカルパインを阻害し、カルパイン阻害物質の分解を減少させることができる。 | ||||||
MG-115 | 133407-86-0 | sc-221940 sc-221940A | 1 mg 5 mg | $87.00 $220.00 | 3 | |
ペプチドのアルデヒド阻害剤で、カルパインの活性部位に結合することにより、カルパインのプロテアーゼ活性を阻害する。 |